AnandRathi

Glaxosmithkline Pharmaceuticals Ltd Fundamental Analysis

Last Updated Date: 21 Sept 2026
₹2,845.40
-6.45 (-0.23%)

Glaxosmithkline Pharmaceuticals Ltd (Glaxosmi. Pharma) fundamental analysis breaks down the key financial metrics of the mid-cap Pharmaceuticals company, which carries a market capitalisation of ₹48,312 crore.

Glaxosmithkline Pharmaceuticals Ltd Overview

Market cap₹48,312 Crs
Volume2,238
Prev. Close₹2,851.85
Year range₹2,088.00 - ₹3,121.10
ISININE159A01016

Glaxosmithkline Pharmaceuticals Ltd Fundamentals

ROCE(TTM)60.63%
P/E Ratio (TTM)45.56
P/B Ratio21.56
Debt to Equity0.01
ROE45.15%
EPS (TTM)62.48
Dividend Yield2.00%
Book Value132.30
Profit Margin27.07%
Operating Margin32.63%

Glaxosmithkline Pharmaceuticals Ltd Historical Performance

1 Month Return-1.09%
6 Month Return17.11%
3 Year Return79.27%
3 Month Return25.81%
1 Year Return3.73%
5 Year Return89.97%

Glaxosmithkline Pharmaceuticals Ltd Share Price History

High:0.00
Low:0.00
No History Available

Disclaimer

The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...

Frequently Asked Questions

Download TradeMobi App

  • Real-Time Market Data
  • Advanced Trading Tools
  • Expert-Backed Research